Livagen is a synthetic bioregulatory peptide being studied for its role in regulating DNA structure and gene expression. Research interest centers on its proposed capacity to promote chromatin decondensation, with effects most extensively studied in lymphocyte models alongside investigations into immune system modulation across cardiac, gastrointestinal, and neural tissue models. Research applications include chromatin structure research, immune signalling pathway studies, and nociceptive pathway investigation.
Related products
Sale!
New
Bioregulator
Sale!
New
Bioregulator
Sale!
New
Bioregulator
Sale!
New
Bioregulator
New
New
Sale!
New
Bioregulator
Sale!
New
Bioregulator


